Irreversible dual inhibitory mode: the novel Btk inhibitor PLS-123 demonstrates promising anti-tumor activity in human B-cell lymphoma

The B-cell receptor (BCR) signaling pathway has gained significant attention as a therapeutic target in B-cell malignancies. Recently, several drugs that target the BCR signaling pathway, especially the Btk inhibitor ibrutinib, have demonstrated notable therapeutic effects in relapsed/refractory pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Ning, Li, Xitao, Shi, Yunfei, Ping, Lingyan, Wu, Lina, Fu, Kai, Feng, Lixia, Zheng, Xiaohui, Song, Yuqin, Pan, Zhengying, Zhu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558140/
https://www.ncbi.nlm.nih.gov/pubmed/25944695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558140/
https://www.ncbi.nlm.nih.gov/pubmed/25944695

Ejemplares similares